Measured Wealth Private Client Group, LLC Jazz Pharmaceuticals PLC Transaction History
Measured Wealth Private Client Group, LLC
- $330 Million
- Q2 2025
A detailed history of Measured Wealth Private Client Group, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 4,855 shares of JAZZ stock, worth $676,447. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,855
Previous 3,301
47.08%
Holding current value
$676,447
Previous $409,000
25.92%
% of portfolio
0.16%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
565Shares Held
62.3MCall Options Held
563KPut Options Held
79.8K-
Black Rock Inc. New York, NY6.15MShares$856 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$849 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$356 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$355 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$354 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.73B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...